MP33-18 LOSS OF FOXA2 IN NEUROENDOCRINE PROSTATE CANCER LEADS TO INDUCTION OF FUNCTIONAL ANDROGEN RECEPTOR
نویسندگان
چکیده
You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology I (MP33)1 Sep 2021MP33-18 LOSS OF FOXA2 IN NEUROENDOCRINE PROSTATE CANCER LEADS TO INDUCTION FUNCTIONAL ANDROGEN RECEPTOR Zachary M. Connelly, Shu Yang, Siyuan Cheng, and Xiuping Yu ConnellyZachary Connelly More articles by this author , YangShu Yang ChengSiyuan Cheng YuXiuping View All Author Informationhttps://doi.org/10.1097/JU.0000000000002042.18AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prostate cancer (PCa) is the leading diagnosed in American men. Current treatments for PCa include surgery, radiation, hormone therapy. The gold standard therapeutic interventions treatment with anti-androgens; however, can relapse castration-resistant eventually neuroendocrine prostate (NEPCa). NEPCa most aggressive form a life expectancy less than year following diagnosis no available treatment. Hallmarks loss androgen receptor (AR), expression neuronal markers such as synaptophysin, chromogranin A, FOXA2, well morphological changes resembling stem-like phenotype. pioneer transcription factor expressed embryonically silenced until phenotype occurs. Understanding roles crucial understanding development progression. METHODS: was stably knocked down PC3 cells (PC3/FOXA2-KD). Additionally, overexpressed adenocarcinoma (LNCaP). were subjected RNA protein analysis. Immunofluorescence used visualize AR. Further downstream AR target genes mRNA RESULTS: When cells, increased at both transcript levels. LNCaP where overexpressed, levels decreased. In AR-null down, localized nucleus upon stimulation (Figure 1). Furthermore, stimulation, PC3/FOXA2-KD stimulated including PSA TMPRSS2. Overall, when re-expressed, shows proper nuclear localization, lastly functional. CONCLUSIONS: mechanisms how progresses into loses major remains unclear. We provide some first evidence inversely correlates expression. By further FOXA2’s role through its regulation expression, previous FOXA2-positive/AR-null may be susceptible anti-androgens again. Source Funding: FWCC/Foundation Legacy Funds XY Funding, Office SEED awards, Department Biochemistry Molecular Biology © 2021 Urological Association Education Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e613-e614 Advertisement Copyright Permissions© Inc.MetricsAuthor Information Expand Loading ...
منابع مشابه
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
Emergence of androgen-independent cancer cells during androgen deprivation therapy presents a significant challenge to successful treatment outcomes in prostate cancer. Elucidating the role of androgen deprivation in the transition from an androgen-dependent to an androgen-independent state may enable the development of more effective therapeutic ...
متن کاملCancer Therapy: Preclinical Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer
Purpose:Mechanisms mediating androgen receptor (AR) reactivation in prostate cancer that progresses after castration (castration-resistant prostate cancer; CRPC) and subsequent treatment with abiraterone (CYP17A1 inhibitor that further suppresses androgen synthesis) remain unclear. Experimental Design: Prostate cancer xenografts were examined to identify mechanism of progression after castratio...
متن کاملAndrogen receptor in prostate cancer.
The normal development and maintenance of the prostate is dependent on androgen acting through the androgen receptor (AR). AR remains important in the development and progression of prostate cancer. AR expression is maintained throughout prostate cancer progression, and the majority of androgen-independent or hormone refractory prostate cancers express AR. Mutation of AR, especially mutations t...
متن کاملRapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.
PURPOSE Mechanisms mediating androgen receptor (AR) reactivation in prostate cancer that progresses after castration (castration-resistant prostate cancer; CRPC) and subsequent treatment with abiraterone (CYP17A1 inhibitor that further suppresses androgen synthesis) remain unclear. EXPERIMENTAL DESIGN Prostate cancer xenografts were examined to identify mechanism of progression after castrati...
متن کامل[Androgen-deprivation therapy in the management of neuroendocrine prostate cancer].
BACKGROUND Prostatic neuroendocrine carcinomas comprise <1% of all prostate neoplasms, and approximately 200 cases have been reported in the literature. We undertook this study to describe the experience in the management of prostatic neuroendocrine carcinoma with androgen-deprivation therapy (ADT). METHODS We designed a retrospective, descriptive and observational study. In patients with sus...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Urology
سال: 2021
ISSN: ['0022-5347', '1527-3792']
DOI: https://doi.org/10.1097/ju.0000000000002042.18